PBAX News and Press, Phoenix Biotech Acquisition Corp.

Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) (“PBAX”) and CERo Therapeutics, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms (“CERo”) today announced that their prev...

A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 118.4% to $0.1162 on volume of 394,556,402 shares U Power Limited (UCAR) rose 45.5% to $0.0959 on volume of 274,384,293 shares Palantir Technologies Inc. Class A (PLTR) rose 3.9% to $24.51 on v...

A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 164.5% to $0.1407 on volume of 378,097,862 shares U Power Limited (UCAR) rose 55.6% to $0.102517 on volume of 264,170,127 shares Palantir Technologies Inc. Class A (PLTR) rose 5.8% to $24.965 o...

2024-02-08 12:23:40 ET Read the full article on Seeking Alpha For further details see: SUNW, NSTG and NERV among mid-day movers

A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 7.9% to $23.6 on volume of 254,911,069 shares MicroCloud Hologram Inc. (HOLO) rose 1092.1% to $18 on volume of 194,069,467 shares Snap Inc. Class A (SNAP) fell 34.6% to $11.41 on volume o...

A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 8.5% to $23.725 on volume of 224,436,172 shares MicroCloud Hologram Inc. (HOLO) rose 602.0% to $10.6 on volume of 173,635,213 shares Snap Inc. Class A (SNAP) fell 34.8% to $11.37 on volum...

2024-02-05 12:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-15 07:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-06-05 17:00:17 ET SPAC Phoenix Biotech Acquisition Corp. ( NASDAQ: PBAX ) has agreed to merge with T-cell therapy developer CERo Therapeutics (CERO). The deal values CERo at a pre-money equity value of $50M. The market capitalization of the combined company is expected to b...

CERo is an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Its lead product candidate is expected to enter clinical trials in 2024. Anticipated cash resources will fund the advancement of CERo...